Baker Tilly Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Sell
9,590
-1,030
-10% -$26.9K 0.05% 259
2026
Q1
$298K Sell
10,620
-758
-7% -$20.2K 0.07% 211
2025
Q4
$283K Buy
11,378
+1,449
+15% +$36.5K 0.07% 229
2025
Q3
$253K Buy
+9,929
New +$245K 0.06% 240
2024
Q2
Sell
-20,681
Closed -$574K 379
2024
Q1
$574K Sell
20,681
-5,078
-20% -$141K 0.1% 221
2023
Q4
$742K Sell
25,759
-47,968
-65% -$1.45M 0.12% 181
2023
Q3
$2.45M Sell
73,727
-25,379
-26% -$897K 0.4% 54
2023
Q2
$3.64M Buy
99,106
+5,973
+6% +$232K 0.38% 62
2023
Q1
$3.8M Sell
93,133
-7,437
-7% -$321K 0.43% 52
2022
Q4
$5.15M Buy
100,570
+3,930
+4% +$188K 0.63% 32
2022
Q3
$4.23M Buy
96,640
+1,419
+1% +$69K 0.58% 33
2022
Q2
$4.99M Buy
95,221
+5,348
+6% +$273K 0.65% 32
2022
Q1
$4.65M Sell
89,873
-3,212
-3% -$167K 0.52% 40
2021
Q4
$5.5M Buy
93,085
+4,593
+5% +$228K 0.59% 34
2021
Q3
$3.81M Buy
88,492
+15,806
+22% +$700K 0.5% 40
2021
Q2
$2.85M Buy
72,686
+7,336
+11% +$285K 0.46% 45
2021
Q1
$2.37M Buy
65,350
+27,308
+72% +$970K 0.49% 43
2020
Q4
$1.4M Buy
+38,042
New +$1.4M 0.43% 53

Other funds holding PFE

Baker Tilly Wealth Management's PFE Position: Q2 2026 in Review

Baker Tilly Wealth Management reduced its Pfizer (PFE) stake by 9.7% in Q2 2026, selling an estimated $26.9K and leaving 9,590 shares worth $231K. The position accounts for 0.05% of the portfolio, ranked #259.

Baker Tilly Wealth Management first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $5.5M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Baker Tilly Wealth Management held 9,590 shares of Pfizer worth $231K as of Q2 2026.
  • Baker Tilly Wealth Management sold 1,030 Pfizer shares in Q2 2026, an estimated $26.9K.
  • Pfizer made up 0.05% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #259 holding.
  • Baker Tilly Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
  • Baker Tilly Wealth Management's Pfizer position peaked at $5.5M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.